Blue Fin Capital Inc. Sells 160 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Blue Fin Capital Inc. cut its position in iShares Biotechnology ETF (NASDAQ:IBB) by 1.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,319 shares of the financial services provider’s stock after selling 160 shares during the quarter. Blue Fin Capital Inc.’s holdings in iShares Biotechnology ETF were worth $1,364,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Bank of America Corp DE grew its position in shares of iShares Biotechnology ETF by 6.5% in the 4th quarter. Bank of America Corp DE now owns 7,489,427 shares of the financial services provider’s stock valued at $990,177,000 after acquiring an additional 460,154 shares during the period. Raymond James Financial Inc. acquired a new stake in iShares Biotechnology ETF in the 4th quarter valued at about $55,010,000. Generali Investments CEE investicni spolecnost a.s. bought a new position in iShares Biotechnology ETF during the fourth quarter worth about $11,370,000. Focus Partners Wealth increased its position in iShares Biotechnology ETF by 168.2% during the fourth quarter. Focus Partners Wealth now owns 121,996 shares of the financial services provider’s stock worth $16,485,000 after buying an additional 76,509 shares during the last quarter. Finally, Independent Advisor Alliance bought a new stake in iShares Biotechnology ETF in the fourth quarter valued at approximately $6,769,000. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Trading Down 2.4%

Shares of NASDAQ IBB opened at $121.69 on Thursday. The company has a market capitalization of $5.32 billion, a P/E ratio of 23.96 and a beta of 0.84. iShares Biotechnology ETF has a 12 month low of $107.43 and a 12 month high of $150.57. The stock has a 50 day moving average of $123.13 and a 200-day moving average of $132.38.

iShares Biotechnology ETF Increases Dividend

The business also recently disclosed a dividend, which was paid on Friday, March 21st. Shareholders of record on Tuesday, March 18th were given a dividend of $0.1212 per share. The ex-dividend date was Tuesday, March 18th. This is an increase from iShares Biotechnology ETF’s previous dividend of $0.06.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.